Abstract
This study aimed to identify the underlying genetic mutation in patients with hypophosphatemic rickets (HR). Genomic DNA was analysed for mutations in PHEX, FGF23 and CLCN5 by polymerase chain reaction (PCR) followed by denaturing high-performance liquid chromatography (dHPLC). Bi-directional sequencing was performed in samples with deviating chromatographic profiles. DMP1 and SLC34A3 were sequenced, only. In addition, a multiplex ligation-dependent probe amplification (MLPA) analysis was performed to detect larger deletions/duplications in PHEX or FGF23. Familial cases accounted for 12 probands while 12 cases were sporadic. In 20 probands, mutations were detected in PHEX of which 12 were novel, and one novel frameshift mutation was found in DMP1. Three PHEX mutations were identified by the MLPA analysis only; that is, two large deletions and one duplication. No mutations were identified in FGF23, SLC34A3 or CLCN5. By the methods used, a disease causing mutation was identified in 83% of the familial and 92% of the sporadic cases, thereby in 88% of the tested probands. Genetic analysis performed in HR patients by PCR, dHPLC, sequencing and in addition by MLPA analysis revealed a high identification rate of gene mutations causing HR, including 12 novel PHEX and one novel DMP1 mutation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Beck-Nielsen, S. S., Brock-Jacobsen, B., Gram, J., Brixen, K., Jensen, T. K. Incidence and prevalence of nutritional and hereditary rickets in Southern Denmark. Eur. J. Endocrinol. 160, 491–497 (2009).
Albright, F., Butler, A. M., Bloomberg, E. Rickets resistant to vitamin D therapy. Am. J. Dis. Child 54, 529–547 (1937).
Beck-Nielsen, S. S., Brusgaard, K., Rasmussen, L. M., Brixen, K., Brock-Jacobsen, B., Poulsen, M. R. et al. Phenotype presentation of hypophosphatemic rickets in adults. Calcif. Tissue Int. 87, 108–119 (2010).
The HYP Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat. Genet. 11, 130–136 (1995).
The ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345–348 (2000).
Lorenz-Depiereux, B., Bastepe, M., et-Pages, A., Amyere, M., Wagenstaller, J., Muller-Barth, U. et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 38, 1248–1250 (2006).
Levy-Litan, V., Hershkovitz, E., Avizov, L., Leventhal, N., Bercovich, D., Chalifa-Caspi, V. et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am. J. Hum. Genet. 86, 273–278 (2010).
Lorenz-Depiereux, B., Schnabel, D., Tiosano, D., Hausler, G., Strom, T. M. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am. J. Hum. Genet. 86, 267–272 (2010).
Bastepe, M., Juppner, H. Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev. Endocr. Metab. Disord. 9, 171–180 (2008).
Bergwitz, C., Roslin, N. M., Tieder, M., Loredo-Osti, J. C., Bastepe, M., bu-Zahra, H. et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am. J. Hum. Genet. 78, 179–192 (2006).
Lorenz-Depiereux, B., et-Pages, A., Eckstein, G., Tenenbaum-Rakover, Y., Wagenstaller, J., Tiosano, D. et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am. J. Hum. Genet. 78, 193–201 (2006).
Brakemeier, S., Si, H., Gollasch, M., Hoffler, D., Buhl, M., Kohler, R. et al. Dent's disease: identification of a novel mutation in the renal chloride channel CLCN5. Clin. Nephrol. 62, 387–390 (2004).
Cho, H. Y., Lee, B. H., Choi, H. J., Ha, I. S., Choi, Y., Cheong, H. I. Renal manifestations of Dent disease and Lowe syndrome. Pediatr. Nephrol. 23, 243–249 (2008).
Carpenter, T. O., Imel, E. A., Holm, I. A., Jan de Beur, S. M., Insogna, K. L. A clinician's guide to X-linked hypophosphatemia. J. Bone Miner. Res. 26, 1381–1388 (2011).
Chaussain-Miller, C., Sinding, C., Wolikow, M., Lasfargues, J. J., Godeau, G., Garabedian, M. Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J. Pediatr. 142, 324–331 (2003).
Chaussain-Miller, C., Sinding, C., Septier, D., Wolikow, M., Goldberg, M., Garabedian, M. Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis. 13, 482–489 (2007).
Makitie, O., Doria, A., Kooh, S. W., Cole, W. G., Daneman, A., Sochett, E. Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 88, 3591–3597 (2003).
Goji, K., Ozaki, K., Sadewa, A. H., Nishio, H., Matsuo, M. Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait. J. Clin. Endocrinol. Metab. 91, 365–370 (2006).
Lloyd, S. E., Pearce, S. H., Gunther, W., Kawaguchi, H., Igarashi, T., Jentsch, T. J. et al. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). J. Clin. Invest. 99, 967–974 (1997).
Ruppe, M. D., Brosnan, P. G., Au, K. S., Tran, P. X., Dominguez, B. W., Northrup, H. Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets. Clin. Endocrinol. 74, 312–318 (2011).
Jap, T. S., Chiu, C. Y., Niu, D. M., Levine, M. A. Three novel mutations in the PHEX gene in Chinese subjects with hypophosphatemic rickets extends genotypic variability. Calcif. Tissue Int. 88, 370–377 (2011).
Clausmeyer, S., Hesse, V., Clemens, P. C., Engelbach, M., Kreuzer, M., Becker-Rose, P. et al. Mutational analysis of the PHEX gene: novel point mutations and detection of large deletions by MLPA in patients with X-linked hypophosphatemic rickets. Calcif. Tissue Int. 85, 211–220 (2009).
Kienitz, T., Ventz, M., Kaminsky, E., Quinkler, M., Novel, P. H. E. X. Nonsense mutation in a patient with X-linked hypophosphatemic rickets and review of current therapeutic regimens. Exp. Clin. Endocrinol. Diabetes 119, 431–435 (2011).
Turner, A. J., Tanzawa, K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 11, 355–364 (1997).
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947–2948 (2007).
Oefner, C., D'Arcy, A., Hennig, M., Winkler, F. K., Dale, G. E. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J. Mol. Biol. 296, 341–349 (2000).
Cho, H. Y., Lee, B. H., Kang, J. H., Ha, I. S., Cheong, H. I., Choi, Y. A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr. Res. 58, 329–333 (2005).
Dixon, P. H., Christie, P. T., Wooding, C., Trump, D., Grieff, M., Holm, I. et al. Mutational analysis of PHEX gene in X-linked hypophosphatemia. J. Clin. Endocrinol. Metab. 83, 3615–3623 (1998).
Francis, F., Strom, T. M., Hennig, S., Boddrich, A., Lorenz, B., Brandau, O. et al. Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res. 7, 573–585 (1997).
Gaucher, C., Walrant-Debray, O., Nguyen, T. M., Esterle, L., Garabedian, M., Jehan, F. PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum. Genet. 125, 401–411 (2009).
Popowska, E., Pronicka, E., Sulek, A., Jurkiewicz, D., Rowe, P., Rowinska, E. et al. X-linked hypophosphatemia in Polish patients. 1. Mutations in the PHEX gene. J. Appl. Genet. 41, 293–302 (2000).
Rowe, P. S., Oudet, C. L., Francis, F., Sinding, C., Pannetier, S., Econs, M. J. et al. Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum. Mol. Genet. 6, 539–549 (1997).
Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B. et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 38, 1310–1315 (2006).
Koshida, R., Yamaguchi, H., Yamasaki, K., Tsuchimochi, W., Yonekawa, T., Nakazato, M. A novel nonsense mutation in the DMP1 gene in a Japanese family with autosomal recessive hypophosphatemic rickets. J. Bone Miner. Metab. 28, 585–590 (2010).
Makitie, O., Pereira, R. C., Kaitila, I., Turan, S., Bastepe, M., Laine, T. et al. Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation. J. Bone Miner. Res. (2010).
Turan, S., Aydin, C., Bereket, A., Akcay, T., Guran, T., Yaralioglu, B. A. et al. Identification of a novel dentin matrix protein-1 (DMP-1) mutation and dental anomalies in a kindred with autosomal recessive hypophosphatemia. Bone 46, 402–409 (2010).
Morey, M., Castro-Feijoo, L., Barreiro, J., Cabanas, P., Pombo, M., Gil, M. et al. Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type. BMC. Med. Genet. 12, 116 (2011).
Holm, I. A., Nelson, A. E., Robinson, B. G., Mason, R. S., Marsh, D. J., Cowell, C. T. et al. Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 86, 3889–3899 (2001).
Ichikawa, S., Traxler, E. A., Estwick, S. A., Curry, L. R., Johnson, M. L., Sorenson, A. H. et al. Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone 43, 663–666 (2008).
Song, H. R., Park, J. W., Cho, D. Y., Yang, J. H., Yoon, H. R., Jung, S. C. PHE X gene mutations and genotype-phenotype analysis of korean patients with hypophosphatemic rickets. J. Korean Med. Sci. 22, 981–986 (2007).
Tyynismaa, H., Kaitila, I., Nanto-Salonen, K., la-Houhala, M., Alitalo, T. Identification of fifteen novel PHEX gene mutations in Finnish patients with hypophosphatemic rickets. Hum. Mutat. 15, 383–384 (2000).
Carpenter, T. O. The expanding family of hypophosphatemic syndromes. J. Bone Miner. Metab. 30, 1–9 (2012).
Yamazaki, Y., Okazaki, R., Shibata, M., Hasegawa, Y., Satoh, K., Tajima, T. et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J. Clin. Endocrinol. Metab. 87, 4957–4960 (2002).
Ito, N., Fukumoto, S., Takeuchi, Y., Yasuda, T., Hasegawa, Y., Takemoto, F. et al. Comparison of two assays for fibroblast growth factor (FGF)-23. J. Bone Miner. Metab. 23, 435–440 (2005).
Carpenter, T. O., Insogna, K. L., Zhang, J. H., Ellis, B., Nieman, S., Simpson, C. et al. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J. Clin. Endocrinol. Metab. 95, E352–E357 (2010).
Beck-Nielsen, S. S. Rickets in Denmark. Dan. Med. J. 59, B4384 (2012).
Imel, E. A., Peacock, M., Pitukcheewanont, P., Heller, H. J., Ward, L. M., Shulman, D. et al. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J. Clin. Endocrinol. Metab. 91, 2055–2061 (2006).
Larsson, T., Nisbeth, U., Ljunggren, O., Juppner, H., Jonsson, K. B. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 64, 2272–2279 (2003).
Acknowledgements
This study was funded by grants from AJ Andersen og Hustrus Fond, the AP Moeller Foundation for the Advancement of Medical Science, Herta Christensens Fond, Institute of Clinical Research, University of Southern Denmark, Direktoer Jacob Madsen og Hustru Olga Madsens Fond, Karola Joergensens Forskningsfond, KA Rohde og Hustrus legat, Simon Fougner Hartmanns Familiefond, Else Poulsens mindelegat, and Institut for Regional Sundhedsforskning.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beck-Nielsen, S., Brixen, K., Gram, J. et al. Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet 57, 453–458 (2012). https://doi.org/10.1038/jhg.2012.56
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2012.56
Keywords
This article is cited by
-
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia
Nature Reviews Endocrinology (2022)
-
Novel variants and uncommon cases among southern Chinese children with X-linked hypophosphatemia
Journal of Endocrinological Investigation (2020)
-
Mineralized tissues in hypophosphatemic rickets
Pediatric Nephrology (2020)
-
Clinical Characteristics and Bone Features of Autosomal Recessive Hypophosphatemic Rickets Type 1 in Three Chinese Families: Report of Five Chinese Cases and Review of the Literature
Calcified Tissue International (2020)
-
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Orphanet Journal of Rare Diseases (2019)
